Company intelligence / Profile preview

MAK Scientific Management

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

MAK Scientific is a biotechnology company focused on the discovery and development of small molecule therapeutics targeting the endocannabinoid system. The company leverages its expertise in medicinal chemistry and pharmacology to create modulators of cannabinoid receptors and enzymes involved in endocannabinoid metabolism, such as FAAH and MAGL. Their research aims to address significant unmet medical needs in chronic pain, inflammation, and metabolic disorders. MAK Scientific operates primarily through a collaborative model, often working with academic institutions to advance its early-stage pipeline.

Therapeutic areas: PsychiatryImmunologyNeurologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

AM1710

Preclinical

Beyond the preview

Go deeper on MAK Scientific Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAK Scientific Management.

Explore the full profile